The effect of the administration of HN2 on the utilization of plasma iron
1958; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês
10.1002/1097-0142(195801/02)11
ISSN1097-0142
AutoresAlbert Bertinchamps, Y. Kenis, H. J. Tagnon, T. Peltzer, L. Vanderauwera,
Tópico(s)Epigenetics and DNA Methylation
ResumoCancerVolume 11, Issue 1 p. 117-121 ArticleFree Access The effect of the administration of HN2 on the utilization of plasma iron A. Bertinchamps M.D., A. Bertinchamps M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, Belgium Fellow of the Institut Interuniversitaire des Sciences Nucléaires.Search for more papers by this authorY. Kenis M.D., Y. Kenis M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorH. J. Tagnon M.D., H. J. Tagnon M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorT. Peltzer, T. Peltzer Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorL. Vanderauwera, L. Vanderauwera Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this author A. Bertinchamps M.D., A. Bertinchamps M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, Belgium Fellow of the Institut Interuniversitaire des Sciences Nucléaires.Search for more papers by this authorY. Kenis M.D., Y. Kenis M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorH. J. Tagnon M.D., H. J. Tagnon M.D. Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorT. Peltzer, T. Peltzer Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this authorL. Vanderauwera, L. Vanderauwera Department of Medicine and Clinical Investigation of the Institut Jules Bordet, Centre Anticancéreux de l'Université Libre de Bruxelles, Brussels, BelgiumSearch for more papers by this author First published: January/February 1958 https://doi.org/10.1002/1097-0142(195801/02)11:1 3.0.CO;2-2Citations: 9 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Bollag, W.: Tierexperimentelle Untersuchungen über die Wirkung einiger Cytostatika auf das Blutbild. Schweiz. med. Wchnachr. 83: 1027– 1029, 1953. 2 Goodman, L. S.; Wintrobe, M. M.; McLennan, M. T.; Dameshek, W.; Goodman, M. J., and Gilman, A.: Use of methyl-bis(β-chloroethyl)amine hydrochloride and tris(β-chloroethyl)amine hydrochloride (“nitrogen-mustards”) in therapy of Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. [A.A.A.S.] Approaches to Tumor Chemotherapy, 1947; pp. 338– 346. 3 Hamilton, L. D.; Gubler, C. J.; Cartwright, G. E., and Wintrobe, M. M.: Diurnal variation in plasma iron level of man. Proc. Soc. Exper. Biol. & Med. 75: 65– 68, 1950. 4 Hennessy, T. G., and Huff, R. L.: Depression of tracer ion uptake curve in rat erythrocytes following total body x-irradiation. Proc. Soc. Exper. Biol. & Med. 73: 436– 439, 1950. 5 Huff, R. L.; Hennessy, T. G.; Austin, R. E.; Garcia, J. F.; Roberts, B. M., and Lawrence, J. H.: Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders. J. Clin. Investigation 29: 1041– 1052, 1950. 6 Karnofsky, D. A.; Burchenal, J. H.; Ormsbee, R. A.; Cornman, I., and Rhoads, C. P.: Experimental observations on use of nitrogen mustards in treatment of neoplastic disease. [A.A.A.S.] Approaches to Tumor Chemotherapy, 1947; pp. 293– 305. 7 Karnofsky, D. A.; Craver, L. F.; Rhoads, C. P., and Abels, J. C.: Evaluation of methyl-bis(β-chloroethyl)amine hydrochloride and tris(β-chloroethyl)amine hydrochloride (nitrogen mustards) in treatment of lymphomas, leukemia and allied diseases. [A.A.A.S.] Approaches to Tumor Chemotherapy, 1947; pp. 319– 337. 8 Loeffler, R. K.; Collins, V. P., and Hyman, G. A.: Comparative effects of total body radiation, nitrogen mustard, and triethylene melamine on hematopoietic system of terminal cancer patients. Science 118: 161– 163, 1953. 9 Philips, F. S., and Gilman, A.: Relation between chemical constitution and biological action of nitrogen mustards. [A.A.A.S.] Approaches to Tumor Chemotherapy, 1947; pp. 285– 292. 10 Shen, S. C., and Homburger, F.: Anemia of cancer patients and its relation to metastases to bone marrow. J. Lab. & Clin. Med. 37: 182– 198, 1951. 11 Spurr, C. L.; Jacobson, L. O.; Smith, T. R., and Guzman Barron, E. S.: Clinical application of methyl-bis(β-chloroethyl)amine hydrochloride to treatment of lymphomas and allied dyscrasias. [A.A.A.S.] Approaches to Tumor Chemotherapy, 1947; pp. 306– 318. Citing Literature Volume11, Issue1January/February 1958Pages 117-121 ReferencesRelatedInformation
Referência(s)